| G–quadruplex RNA structure as a signal for neurite mRNA targeting M Subramanian, F Rage, R Tabet, E Flatter, JL Mandel, H Moine EMBO reports 12 (7), 697-704, 2011 | 284 | 2011 |
| Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor/ataxia syndrome C Sellier, F Freyermuth, R Tabet, T Tran, F He, F Ruffenach, V Alunni, ... Cell reports 3 (3), 869-880, 2013 | 264 | 2013 |
| Polyglutamine-expanded huntingtin exacerbates age-related disruption of nuclear integrity and nucleocytoplasmic transport F Gasset-Rosa, C Chillon-Marinas, A Goginashvili, RS Atwal, JW Artates, ... Neuron 94 (1), 48-57. e4, 2017 | 248 | 2017 |
| Disruption of RNA metabolism in neurological diseases and emerging therapeutic interventions JK Nussbacher, R Tabet, GW Yeo, C Lagier-Tourenne Neuron 102 (2), 294-320, 2019 | 244 | 2019 |
| CUG initiation and frameshifting enable production of dipeptide repeat proteins from ALS/FTD C9ORF72 transcripts R Tabet, L Schaeffer, F Freyermuth, M Jambeau, M Workman, CZ Lee, ... Nature communications 9 (1), 152, 2018 | 158 | 2018 |
| Fragile X Mental Retardation Protein (FMRP) controls diacylglycerol kinase activity in neurons R Tabet, E Moutin, JAJ Becker, D Heintz, L Fouillen, E Flatter, W Krężel, ... Proceedings of the National Academy of Sciences 113 (26), E3619-E3628, 2016 | 118 | 2016 |
| A Novel Role for the RNA–Binding Protein FXR1P in Myoblasts Cell-Cycle Progression by Modulating p21/Cdkn1a/Cip1/Waf1 mRNA Stability L Davidovic, N Durand, O Khalfallah, R Tabet, P Barbry, B Mari, S Sacconi, ... PLoS genetics 9 (3), e1003367, 2013 | 82 | 2013 |
| Fragile X syndrome: are signaling lipids the missing culprits? R Tabet, N Vitale, H Moine Biochimie 130, 188-194, 2016 | 21 | 2016 |
| AAV‐delivered diacylglycerol kinase DGKk achieves long‐term rescue of fragile X syndrome mouse model K Habbas, O Cakil, B Zámbó, R Tabet, F Riet, D Dembele, JL Mandel, ... EMBO Molecular Medicine 14 (5), e14649, 2022 | 11 | 2022 |
| Comprehensive evaluation of human-derived anti-poly-GA antibodies in cellular and animal models of C9orf72 disease M Jambeau, KD Meyer, M Hruska-Plochan, R Tabet, CZ Lee, A Ray-Soni, ... Proceedings of the National Academy of Sciences 119 (49), e2123487119, 2022 | 10 | 2022 |
| CUG initiation and frameshifting enable production of dipeptide repeat proteins from ALS/FTD C9ORF72 transcripts. Nat Commun 9: 152 R Tabet, L Schaeffer, F Freyermuth, M Jambeau, M Workman, CZ Lee, ... doi. org/10.1038/s4146, 7-017, 2018 | 9 | 2018 |
| AAV-mediated gene therapy rescues GALT activity and reduces ER stress in classic galactosemia ML Brophy, TW Chen, K Le, R Tabet, Y Ahn, JE Murphy, RD Bell MOLECULAR THERAPY 28 (4), 303-303, 2020 | 4 | 2020 |
| AAV-delivery of diacylglycerol kinase kappa achieves long-term rescue of Fmr1-KO mouse model deficits of fragile X syndrome K Habbas, O Cakil, B Zambo, R Tabet, F Riet, D Dembele, JL Mandel, ... bioRxiv, 2021.04. 14.439810, 2021 | 1 | 2021 |
| Recombinant dgkk gene for fragile x syndrome gene therapy H Moine, R Tabet US Patent App. 18/176,500, 2023 | | 2023 |
| Recombinant Dgkk gene for fragile X syndrome gene therapy H Moine, R Tabet US Patent 11,597,936, 2023 | | 2023 |
| Comprehensive preclinical evaluation of human-derived anti-poly-GA antibodies in cellular and animal models of C9ORF72 disease M Jambeau, KD Meyer, M Hruska-Plochan, R Tabet, CZ Lee, A Ray-Soni, ... bioRxiv, 2022.01. 13.475329, 2022 | | 2022 |
| Characterization of New Pfizer AAV Vectors C Shyng, M Michalec, K Zaraspe, T Cheng, R Tabet, LJ Song, JC Pang, ... MOLECULAR THERAPY 29 (4), 174-175, 2021 | | 2021 |
| AAV-Mediated Gene Therapy Rescues GALT Activity and Reduces ER Stress in Classic Galactosemia ML Brophy, TW Cheng, K Le, R Tabet, Y Ahn, J Murphy, R Bell MOLECULAR THERAPY 29 (4), 241-241, 2021 | | 2021 |
| Development of an AAV-GBA Gene Therapy for the Treatment of Type 1 Gaucher Disease TW Cheng, D Souza, R Tabet, K Wright, J Brodfuehrer, L Keyes, ... MOLECULAR THERAPY 29 (4), 251-251, 2021 | | 2021 |
| Selective repression of C9ORF72 repeat expansion-containing sense and antisense transcripts for the treatment of ALS M Samie, A Pattamatta, D Baldwin, S Hinkley, E Tait, N Scarlott, R Tabet, ... MOLECULAR THERAPY 29 (4), 280-280, 2021 | | 2021 |
